Loading clinical trials...
Loading clinical trials...
This clinical trial will try to determine if the supplements magnesium and riboflavin will reduce the pain and duration of headaches in persons diagnosed with a concussion. The participant will be randomized to either active magnesium and riboflavin capsules or placebo (inert) capsules. The capsules will be taken once a day for 14 days. The participant will also complete a short diary form for the 14 days and will have 3 follow up visits either by telephone or in person.
Age
18 - 40 years
Sex
ALL
Healthy Volunteers
No
University of Virginia Student Health and Wellness Center
Charlottesville, Virginia, United States
Start Date
February 10, 2020
Primary Completion Date
December 31, 2025
Completion Date
December 31, 2025
Last Updated
March 27, 2025
108
ESTIMATED participants
magnesium and riboflavin supplement
DRUG
Lead Sponsor
University of Virginia
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT02661633